Targeted therapies to join chemo as oncology treatment backbone
In recent years, the oncology sector has undergone a fundamental shift away from chemotherapy-dominant treatment towards the use of regimens…
Features
Europe’s pharma trade with the US remains critical despite tariff turmoil
How America’s former steel heartland secured a $3.5bn Eli Lilly facility
Podcast: Rare Disease Day: FDA guidance allowing advancement
Rare disease developers applaud clarity in FDA guidance
Nonprofit models support strategic boldness to develop gene therapies for rare diseases
Podcast: Which pharma and medtech companies came out on top in 2025 revenues?
RNA-targeting small molecules: a new frontier of drug discovery
